Clearside Biomedical, Inc. (CLSD)
Clearside Biomedical, Inc. (CLSD)
$1.15 USD
Updated Jul 19 12:00am
Add CLSD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
CLSD News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesClearside Biomedical, Inc. (CLSD) Company Bio
Clearside Biomedical, a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. The company was founded in 2011 and is based in Alpharetta, Georgia
CLSD Stock Chart More Charts
CLSD Price/Volume Stats
| Current price | $1.15 |
| Prev. close | $1.18 |
| Day low | $1.13 |
| Day high | $1.18 |
| 50-day MA | $1.12 |
| 200-day MA | $1.81 |
| 52-week high | $10.13 |
| 52-week low | $0.95 |
| Volume | 131,500 |
| Avg. volume | 699,626 |
| Dividend yield | N/A |
| Market Cap | 43.24M |
CLSD Returns
| 1-mo | 11.65% |
| 3-mo | -8.00% |
| 6-mo | 2.68% |
| 1-year | -88.50% |
| 3-year | -82.28% |
| 5-year | N/A |
| YTD | 7.48% |
| 2018 | -84.71% |
| 2017 | -21.70% |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...